Company: NGVT
Filing Date: 2025-03-20
Form Type: DEFA14A
Source: 0001140361-25-009731
Chunk: 9

Company: Ingevity Corp
Filing Date: 2025-03-20
Form: DEFA14A
Chunk 9
---
 WHITE proxy card FOR Ingevity’s highly qualified and experienced director nominees. For those of you who are Ingevity stockholders, you will also be receiving communications from Vision One. Our Board opposes the election of Vision One’s two nominees and strongly encourages you to simply discard any gold proxy card you may receive from Vision One. While this year’s Annual Meeting will likely receive more attention than usual, I want to reiterate that this has no impact on our daily operations. We have a small team dedicated to this matter and are counting on all of you to remain focused on your day-to-day responsibilities, working safely and delivering for our customers. We are confident in the strides we are making to position the company for the future, driving improved performance and value creation. Thank you for your hard work and dedication to Ingevity and for helping to drive our continued success. Best regards, Luis Fernandez‑Moreno Interim President and CEO Consistent with usual policies, please direct inquiries about this news from media or anyone outside of our company to Caroline Monahan at 843-740-2068 or media@ingevity.com. Stockholder inquiries should be directed to John E. Nypaver, Jr. at 843-740-2002 or investors@ingevity.com. Additional Information and Where to Find It In connection with Ingevity’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”), Ingevity filed on March 20, 2025with the Securities and Exchange Commission (“SEC”) a definitive proxy statement on Schedule 14A (the “Proxy Statement”), containing a form of WHITEproxy card. This communication is not a substitute for the Proxy Statement or any other document that Ingevity has filed or may file with the SEC in connection with any solicitation by Ingevity. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY INGEVITY AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. These documents, including the Proxy Statement (and any amendments or supplements thereto) and other documents filed by Ingevity with the SEC, are available free of charge at the SEC’s website at http://www.sec.gov and at Ingevity’s investor relations website at